Publications & Podcasts
August 27, 2020
News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs
June 18, 2020
FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19
June 12, 2020
FDA Announces New Updates to its Guidance on Conducting Clinical Trials During COVID-19 and Notes Availability of its COVID MyStudies App
March 19, 2020
COVID-19 Expanded Access Template
January 15, 2020
More Proposed Changes to CCPA Geared to Health Care and Life Sciences Industries
October 25, 2019
Proposed Regulations Under the CCPA Provide Some Clarity, But Questions Remain
July 30, 2019
Massachusetts Budget Update: Commonwealth Now Waiting on Governor Baker
February 19, 2019
OIG Proposes Revisions to Anti-Kickback Safe Harbor Regulations Affecting Prescription Drug Rebates
February 11, 2019
Governor Baker’s 2020 Budget Would Allow MassHealth Authority to Negotiate Supplemental Rebates with Pharmaceutical Companies
January 10, 2019
One Month Left to Submit Comments on HIPAA Request for Information
January 10, 2019
Is Cybersecurity on Your 2019 Work Plan?
October 31, 2018
Tag, You’re It: FDA Issues Guidance Ahead of Revisions to its Human Subjects Protection Regulations
July 10, 2018
California Consumer Privacy Act of 2018
June 12, 2018
Federal "Right to Try": Don't Disregard Your State Laws Just Yet!
June 4, 2018
"Right to Try" Comes to the Federal Stage: What Stakeholders Should Do Now
May 24, 2018
Ready or Not...the GDPR Effective Date is Here
